These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6263523)

  • 21. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Lancet; 1986 May; 1(8489):1056-8. PubMed ID: 2871335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method for studying inhibitory activity in whole urine.
    Ryall RL; Hibberd CM; Marshall VR
    Urol Res; 1985; 13(6):285-9. PubMed ID: 3006313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of fenquizone on the urinary inhibitors of calcium oxalate urolithiasis.
    Cupisti A; Ciardella F; Morelli E; Dani L; Lupetti S; Luchi S; Meola M; Barsotti G
    Contrib Nephrol; 1987; 58():184-6. PubMed ID: 3691123
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of trace metals on the inhibition of calcium oxalate crystallization.
    Muñoz JA; Valiente M
    Urol Res; 2005 Aug; 33(4):267-72. PubMed ID: 15937709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of inhibitor deficiency in urolithiasis. I. Rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations.
    Akinci M; Esen T; Koçak T; Ozsoy C; Tellaloğlu S
    Eur Urol; 1991; 19(3):240-3. PubMed ID: 1649759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium oxalate nephrolithiasis: an easy way to detect an imbalance between promoting and inhibiting factors.
    Baggio B; Gambaro G; Oliva O; Favaro S; Borsatti A
    Clin Chim Acta; 1982 Sep; 124(2):149-55. PubMed ID: 6216029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical evaluation of the urinary inhibiting activity in idiopathic calcium oxalate nephrolithiasis.
    Gambaro G; Cicerello E; Marzaro G; Marchini F; Piccoli A; Paleari C; Baggio B
    Urol Int; 1986; 41(6):418-21. PubMed ID: 3824697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
    Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A
    Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artificial simulation of renal stone formation. Influence of some urinary components.
    Grases F; Costa-Bauzá A; March JG; Söhnel O
    Nephron; 1993; 65(1):77-81. PubMed ID: 8413796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of urine on "in vitro" crystallization rate of calcium oxalate: determination of inhibitory activity by a [14C]oxalate technique.
    Ligabue A; Fini M; Robertson WG
    Clin Chim Acta; 1979 Oct; 98(1-2):39-46. PubMed ID: 227625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrophosphate does not influence calcium oxalate or calcium phosphate crystal formation in concentrated whole human urine.
    Hallson PC; Rose GA; Sulaiman S
    Urol Res; 1983; 11(4):151-4. PubMed ID: 6316611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis.
    Fetner CD; Barilla DE; Townsend J; Pak CY
    J Urol; 1978 Oct; 120(4):399-401. PubMed ID: 702659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different estimates of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Eur Urol; 1983; 9(4):231-4. PubMed ID: 6873126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dietary calcium and magnesium on experimental renal tubular deposition of calcium oxalate crystal induced by ethylene glycol administration and its prevention with phytin and citrate.
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Ohkawa T
    Urol Int; 1987; 42(5):330-7. PubMed ID: 3433579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium oxalate dihydrate formation in urine.
    Martin X; Smith LH; Werness PG
    Kidney Int; 1984 Jun; 25(6):948-52. PubMed ID: 6471675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of stone-forming risk by measuring crystal formation in whole urine with gel model.
    Roehrborn CG; Schneider HJ; Rugendorff EW
    Urology; 1986 Jun; 27(6):531-6. PubMed ID: 3716052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of pH on the urinary inhibition of calcium oxalate crystal growth.
    Tiselius HG
    Br J Urol; 1981 Oct; 53(5):470-4. PubMed ID: 6793122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnesium reduces calcium oxalate crystal formation in human whole urine.
    Hallson PC; Rose GA; Sulaiman S
    Clin Sci (Lond); 1982 Jan; 62(1):17-9. PubMed ID: 7056030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.